Non-alcoholic steatofibrosis (NASF) can independently predict mortality in patients with non-alcoholic fatty liver disease (NAFLD)

BACKGROUND: Hepatic fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) independently predicts mortality. Given liver biopsy’s invasive nature, non-invasive method to assess hepatic steatosis and fibrosis provides NAFLD risk stratification algorithm in clinical practice. NAFLD fibros...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:BMJ Open Gastroenterol
Glavni autori: Golabi, Pegah, Stepanova, Maria, Pham, Huong T, Cable, Rebecca, Rafiq, Nila, Bush, Haley, Gogoll, Trevor, Younossi, Zobair M
Format: Artigo
Jezik:Inglês
Izdano: BMJ Publishing Group 2018
Teme:
Hepatology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5873539/
https://ncbi.nlm.nih.gov/pubmed/29607054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2018-000198
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items